PMID: 8981476Dec 13, 1996Paper

Pre- and peristroke treatment with the adenosine kinase inhibitor, 5'-deoxyiodotubercidin, significantly reduces infarct volume after temporary occlusion of the middle cerebral artery in rats

Neuroscience Letters
L P MillerA C Foster

Abstract

The adenosine kinase inhibitor, 5'-deoxyiodotubercidin (5dITU), was examined in a rat focal stoke model with temporary (105 min) middle cerebral artery occlusion (MCAO) followed by a 24 h recovery period. Inhibition of this adenosine metabolizing enzyme indirectly enhances the actions of endogenous adenosine without inducing cardiovascular side effects. Such effects could limit the potential clinical application of any approach targeting adenosine receptor activation. MCAO was accomplished with a transluminal 4-0 nylon suture inserted through the common carotid artery to block blood flow at the origin of the MCA. Treatment with 5dITU 30 min prior to and 5 h after MCAO resulted in a dose dependent (0.1-0.5 mg/kg, i.p.) reduction in infarct volume. A significant (P = 0.02) 44% reduction (control, 265 +/- 35 mm3; treated, 149 +/- 30 mm3) was observed at 0.5 mg/kg. However, at the highest dose examined (1.0 mg/kg) infarct volume was unaffected. To assess the potential for acute (i.e. post-occlusion) treatment, 5dITU was administered (0.33 mg/kg, i.v.) successively at each of 0.5, 1.75 and 3.5 h after MCAO. Post-occlusion treatment resulted in a significant (P = 0.037) 32% reduction in infarct volume (control, 314 +/- 34 mm3; treate...Continue Reading

Citations

Jan 31, 2006·Molecular and Cellular Biochemistry·Jae ParkRadhey S Gupta
Aug 31, 2001·European Journal of Pharmacology·U AdénB B Fredholm
Feb 13, 1999·European Journal of Pharmacology·D K Von Lubitz
Jun 4, 1999·European Journal of Pharmacology·D K von Lubitz
May 26, 1999·Pharmacology, Biochemistry, and Behavior·E A KowalukM F Jarvis
Sep 30, 2000·Brain Research. Brain Research Reviews·A de MendonçaJ A Ribeiro
Sep 19, 2009·Cell Death and Differentiation·D BoisonB B Fredholm
Nov 4, 2000·Expert Opinion on Investigational Drugs·E A Kowaluk, M F Jarvis
Apr 3, 2001·Expert Opinion on Investigational Drugs·D K von Lubitz
Jun 30, 2009·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·V C PimentelM B Moretto
Nov 20, 2015·Neuropharmacology·Felicita PedataAnna Maria Pugliese
Jul 27, 2005·Biochemical and Biophysical Research Communications·Katsuhito NagaiSadaki Fujimoto
Apr 18, 2002·Neurological Research·Hisashi KitagawaTetsuro Kikuchi
Apr 26, 2001·Neurological Research·J W Phillis, H G Goshgarian
Apr 18, 2013·Pharmacological Reviews·Detlev Boison
Mar 18, 2021·Cellular and Molecular Neurobiology·D Pereira-FigueiredoK C Calaza
Dec 8, 1998·Biochemistry·I I MathewsS E Ealick

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.